Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Tharimmune Inc THAR

Healthcare Biotechnology
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for immunology and inflammation conditions in the United States. It is involved in the development of TH104 for the proposed indication of temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders entering and area... see more

Current News (NDAQ:THAR)

Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy

Business Wire December 12, 2025

Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids

PR Newswire November 13, 2025

Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy

PR Newswire November 6, 2025

Tharimmune, Inc. Announces Private Placement of Approximately $540 Million Led by DRW and Liberty City Ventures to Establish Canton Coin Treasury Strategy

PR Newswire November 3, 2025

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

GlobeNewswire September 4, 2025

Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments

ACCESS Newswire August 20, 2025

Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl

ACCESS Newswire August 13, 2025

Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors

ACCESS Newswire August 5, 2025

Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery

ACCESS Newswire August 4, 2025
View More News ››

Opinion & Analysis (NDAQ:THAR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:THAR)

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway
coolfooldumbguy - November 3, 2025

RE:THAR.....I'm going to say it now.....

Now trading at $3.67
Iseneschal - September 5, 2025

THAR.....I'm going to say it now.....

You've all been had......AGAIN !!!! The Pros have shorted the financing to all the FOMO's & Chasers...now all u have to do...
Iseneschal - September 5, 2025

Using technical analysis for this stock.

Otherwise FOMO for you fellas out there today and so good luck to all of you guys
coolfooldumbguy - August 25, 2025

THAR....sell buddy sell

The cheap shares and cheap financing are all finding a new home.....Yes ....thats you The Greater Fools Now $4.72 this a.m
Iseneschal - August 21, 2025

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway so good luck to all of you guys
coolfooldumbguy - August 21, 2025
View more Bullboard ››

Mink Ventures Corp.

Mink Ventures Corp.

Mink Ventures Corporation engages in the acquisition, exploration, and development of mineral property interests in Canada ...
View More »

Podcasts